Hyperglycaemia in CF adversely affects BK channel function critical for mucus clearance
- 14 January 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 57 (1), 2000509
- https://doi.org/10.1183/13993003.00509-2020
Abstract
Large-conductance, Ca2+-activated, voltage-dependent K+ (BK) channel function is critical for adequate airway hydration and mucociliary function. In airway epithelia, BK function is regulated by its γ subunit leucine-rich repeat-containing protein 26 (LRRC26). Since patients with cystic fibrosis (CF)-related diabetes mellitus (CFRD) have worse lung function outcomes, this study determined the effects of hyperglycaemia on BK function in CF bronchial epithelial (CFBE) cells in vitro and evaluated the correlation between glycaemic excursions and mRNA expression of LRRC26 in the upper airways of CF and CFRD patients. CFBE cells were re-differentiated at the air-liquid interface (ALI) in media containing either 5.5 mM or 12.5 mM glucose. BK activities were measured in Ussing chambers. Airway surface liquid (ASL) volumes were estimated by meniscus scanning and inflammatory marker expression was measured by quantitative real-time PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA). CF patients were assessed by 7 days of continuous glucose monitoring. LRRC26 mRNA expression was measured by qPCR from nasal cells obtained at the end of glucose monitoring. BK currents were significantly decreased in CFBE cells cultured under high glucose. These cells revealed significantly lower ASL volumes and increased inflammation, including RAGE, compared to cells cultured in normal glucose. In vivo, nasal cell expression of LRRC26 mRNA was inversely correlated with hyperglycaemic excursions, consistent with the in vitro results. Our findings demonstrate that hyperglycaemia induces inflammation and impairs BK channel function in CFBE cells in vitro. These data suggest that declining lung function in CFRD patients may be related to BK channel dysfunction.Funding Information
- National Center for Advancing Translational Sciences (5UL1TR002366)
- National Heart, Lung, and Blood Institute (R01 HL-133240)
- Cystic Fibrosis Foundation (BENGTS19AC0, SALATH18I0)
This publication has 41 references indexed in Scilit:
- All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responsesPaediatric Respiratory Reviews, 2017
- Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung functionJournal of Cystic Fibrosis, 2016
- Diabetes-related Mortality in Adults with Cystic Fibrosis. Role of Genotype and SexAmerican Journal of Respiratory and Critical Care Medicine, 2015
- The receptor for advanced glycation end-products supports lung tissue biomechanicsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2013
- Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient RegistryEuropean Respiratory Journal, 2013
- Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory DiseasesInternational Journal of Inflammation, 2013
- Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related DiabetesDiabetes Care, 2010
- Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and MortalityDiabetes Care, 2009
- Loss of RAGE in Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002